کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8793986 | 1602775 | 2018 | 17 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Polypoidal Choroidal Vasculopathy
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
intravitreal ranibizumabICGAPDTOCTAAMDRPEPEDBCVAPolypoidal choroidal vasculopathy - vasculopathy کروئیدی polypoidalOCT angiography - آنژیوگرافی OCTIndocyanine green angiography - آنژیوگرافی سبز Indocyaninefluorescein angiography - آنژیوگرافی فلورسینretinal pigment epithelium - اپیتلیوم رنگدانه شبکیهbest-corrected visual acuity - بهترین گشت و گذار تصحیح شدهPigment epithelial detachment - جداسازی اپیتلیال رنگدانهspectral-domain - دامنه طیفیPhotodynamic therapy - درمان فتودینامیکage-related macular degeneration - سن تخریب ماکولا مربوط به سن استVascular endothelial growth factor - فاکتور رشد اندوتلیال عروقیVascular Endothelial Growth Factor (VEGF) - فاکتور رشد اندوتلیال عروقی (VEGF)PCV یا Pneumococcal conjugate vaccine - واکسن کونژوگه پنوموکوک
موضوعات مرتبط
علوم پزشکی و سلامت
پزشکی و دندانپزشکی
چشم پزشکی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Polypoidal choroidal vasculopathy (PCV) is an age-related macular degeneration (AMD) subtype and is seen particularly in Asians. Previous studies have suggested disparity in response to intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents between PCV and typical AMD, and thus, the preferred treatment for PCV has remained unclear. Recent research has provided novel insights into the pathogenesis of PCV, and imaging studies based on OCT suggest that PCV belongs to a spectrum of conditions characterized by pachychoroid, in which disturbance in the choroidal circulation seems to be central to its pathogenesis. Advances in imaging, including enhanced depth imaging, swept-source OCT, en face OCT, and OCT angiography, have facilitated the diagnosis of PCV. Importantly, 2 large, multicenter randomized clinical trials evaluating the safety and efficacy of anti-VEGF monotherapy and combination with photodynamic therapy (PDT) recently reported initial first-year outcomes, providing level I evidence to guide clinicians in choosing the most appropriate therapy for PCV. In this review, we summarize the latest updates in the epidemiologic features, pathogenesis, and advances in imaging and treatment trials, with a focus on the most recent key clinical trials. Finally, we propose current management guidelines and recommendations to help clinicians manage patients with PCV. Remaining gaps in current understanding of PCV, such as significance of polyp closure, high recurrence rate, and heterogeneity within PCV, are highlighted where further research is needed.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Ophthalmology - Volume 125, Issue 5, May 2018, Pages 708-724
Journal: Ophthalmology - Volume 125, Issue 5, May 2018, Pages 708-724
نویسندگان
Chui Ming Gemmy FRCOphth, Timothy Y.Y. MD, Paisan MD, Shih-Jen MD, Youxin MD, K. Bailey MD, Fomi MD, Adrian H. MD, Won-Ki MD, Tien Yin FRCS, PhD,